Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPI 287 in breast cancer metastatic to the brain
NCT01332630Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2011
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abeotaxane in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2011; status: completed.
02
Drugs
abeotaxane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01332630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01332630.